In brain cancer, dynamin 2 is a downstream effector of the PDGFRα-PI3K/SHP-2 signalling in glioma cells and mediates PDGFRα -SHP-2-promoted glioblastoma growth and invasion [45]. Here, DNM2 is linked to central nervous system cancer.